Press Releases and Statements

For the first time, the U.S. Food and Drug Administration (FDA) has assembled a comprehensive webpage with Consumer Medical Device information

This week CHPA filed an amicus brief urging the 9th Circuit U.S. Court of Appeals to confirm an appellate panel’s holding that a class in a class action lawsuit cannot be certified with more than a de minimis number of uninjured class members.

Newest members include manufacturers Alcon, PROFOOT, and Willow Bark Brands, plus 16 associate members.

Janet Woodcock, Cara Welch, other consumer healthcare leaders to discuss emerging trends in OTCs, dietary supplements, and consumer medical devices

Statement on Biden Executive Order Regarding OTC Hearing Aids from Peter Borsuk, Chair of CHPA’s Consumer Medical Devices Council, and President & CEO of Lansinoh Laboratories.

CHPA applauds FDA's inclusion of the publication of a revised version of the New Dietary Ingredient (NDI) Draft Guidance within its priorities for 2022.

Ohio Governor Mike DeWine signed into law HB 9, prohibiting the sale of DXM-containing products to minors.

CHPA awarded its Ivan D. Combe Lifetime Achievement Award Wednesday to longtime industry leader Scott Emerson.

Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors. Goodridge was elected along with six new board members.

CHPA commends Senators Wyden, Paul, and Merkley for their bipartisan bill which will provide a pathway for CBD to be legally marketed as a dietary supplement.

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.